Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bauer K. A., Skarin A. T., Balikian J. P., Garnick M. B., Rosenthal D. S., Canellos G. P. Pulmonary complications associated with combination chemotherapy programs containing bleomycin. Am J Med. 1983 Apr;74(4):557–563. doi: 10.1016/0002-9343(83)91009-4. [DOI] [PubMed] [Google Scholar]
- Cervantes-Perez P., Toro-Perez A. H., Rodriguez-Jurado P. Pulmonary involvement in rheumatoid arthritis. JAMA. 1980 May 2;243(17):1715–1719. [PubMed] [Google Scholar]
- Cooper J. A., Jr, White D. A., Matthay R. A. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis. 1986 Feb;133(2):321–340. doi: 10.1164/arrd.1986.133.2.321. [DOI] [PubMed] [Google Scholar]
- Ginsberg S. J., Comis R. L. The pulmonary toxicity of antineoplastic agents. Semin Oncol. 1982 Mar;9(1):34–51. [PubMed] [Google Scholar]
- Ishizuka M., Takayama H., Takeuchi T., Umezawa H. Activity and toxicity of bleomycin. J Antibiot (Tokyo) 1967 Jan;20(1):15–24. [PubMed] [Google Scholar]
- Matalon S., Harper W. V., Goldinger J. M., Nickerson P. A., Olszowka J. Modification of pulmonary oxygen toxicity by bleomycin treatment. J Appl Physiol (1985) 1985 Jun;58(6):1802–1809. doi: 10.1152/jappl.1985.58.6.1802. [DOI] [PubMed] [Google Scholar]
- Weiss R. B., Muggia F. M. Cytotoxic drug-induced pulmonary disease: update 1980. Am J Med. 1980 Feb;68(2):259–266. doi: 10.1016/0002-9343(80)90364-2. [DOI] [PubMed] [Google Scholar]